Public Company News

Horizon Robotics and DENSO Forge Strategic Partnership to Accelerate Adoption of High-Performance Assisted Driving

SHANGHAI, April 25, 2025 /PRNewswire/ -- Horizon Robotics (stock code: 9660.HK), a leading provider of smart driving solutions for passenger vehicles, announced a strategic partnership with DENSO, a leading mobility supplier, to co-develop competitive assisted driving solutions. By combining Hori...

2025-04-25 18:34 2527

Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results

YANGZHOU, China, April 25, 2025 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, today announced its financial...

2025-04-25 18:05 3155

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors

CHENGDU, China, April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND) approval from the Center for Drug Evaluation (CDE) ...

2025-04-25 17:44 2135

Weibo Corporation to Report First Quarter 2025 Financial Results on May 21, 2025

BEIJING, April 25, 2025 /PRNewswire/ -- Weibo Corporation (NASDAQ: WB and HKEX: 9898), a leading social media for people to create, share and discover content, will announce its unaudited financial results for the first quarter 2025 before the U.S. market opens onWednesday, May 21, 2025. Followin...

2025-04-25 17:00 3348

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Gastrointestinal Cancers

CHENGDU, China, April 24, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") recently announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New Drug (IND) approval from the Center for Drug Evaluation (CD...

2025-04-25 11:37 2318

Horizon Robotics and Bosch Intensify Collaboration to Provide Assisted Driving Solutions for Multiple Automakers

SHANGHAI, April 24, 2025 /PRNewswire/ -- Horizon Robotics (stock code: 9660.HK), a leading provider of smart driving solutions for passenger vehicles, and Bosch, a leading global supplier of automotive technology and services, signed a Memorandum of Understanding (MoU), to intensify their collabo...

2025-04-25 10:45 3877

Animon.ai Debuts as World's First Anime-Specific AI Video Generator

A CreateAI Company, Animon Launches AI Generation Tool from Japan for the World of Anime, Comics, and Games TOKYO, April 24, 2025 /PRNewswire/ -- Animon ("Animon" or the "Company") today introduced Animon.ai, the world's first anime-specific AI video generation platform. Animon.ai was designed i...

2025-04-25 09:30 5099

Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma

HONG KONG, April 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the U.S. Food and Drug Administration (FDA) has approved its differentiated PD-1 monoclonal antibody, penpulimab-kcqx, in combination with cisplatin or carboplatin and gemcitabin...

2025-04-25 08:15 2567

Medit and Graphy Announce Strategic Partnership to Advance Digital Orthodontics

SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, have officially announced a strategic partnership to accelerate advancements in the digital orthodontics market.

2025-04-25 00:00 3240

MicroAlgo Inc. Develops Classical Boosted Quantum Optimization Algorithm (CBQOA)

SHENZHEN, China, April 24, 2025 /PRNewswire/ -- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), announced today the development of an innovative technology, the Classical Boosted Quantum Optimization Algorithm (CBQOA). This algorithm integrates the  search capabilities of classical ...

2025-04-24 22:30 2690

Webull Announces Brand Partnership with Tampa Bay Rays

ST PETERSBURG, Fla., April 24, 2025 /PRNewswire/ -- Webull (NASDAQ: BULL), an online investment platform, today announced a partnership with theTampa Bay Rays and theTampa Bay Rowdies for the 2025 season. Webul...

2025-04-24 21:30 3860

Noah Releases 2024 Chairwoman Letter to Shareholders

SHANGHAI, April 24, 2025 /PRNewswire/ -- Dear Shareholders, On behalf of Noah's Board of Directors (the "Board") and management team, I would like to extend our sincerest gratitude to all shareholders. The year 2024 marked a pivotal chapter in our global expansion, representing a new era of ent...

2025-04-24 21:18 3805

Four AT128 Lidar Sensors from Hesai Selected as Primary Lidar for All Pony.ai Seventh-Generation Robotaxis

SHANGHAI, April 24, 2025 /PRNewswire/ -- Hesai Group (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotic applications, today announced that its long-range, automotive-grade AT128 lidar has been selected as the primary lidar solution for all three mass product...

2025-04-24 20:30 2504

Tuya Filed 2024 Annual Report on Form 20-F and Released Environmental, Social and Governance Report

SANTA CLARA, Calif., April 24, 2025 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced that it has filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2024 with the Securities an...

2025-04-24 20:09 2137

Mabwell to Present Clinical Data of 9MW2821 Combined with Toripalimab in Patients with UC in an Oral Presentation at 2025 ASCO

SHANGHAI, April 24, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that thePhase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 combined with toripalimab in patients with locally advanced...

2025-04-24 20:00 2292

GreenTree Hospitality Group Ltd. Reports Fourth Quarter and Fiscal Year 2024 Financial Results

* Total revenues decreased by 18.2% year over year to RMB304.5 million (US$ 41.7 million)[1]. * Net income was RMB-72.8million (US$-10.0 million)[1] compared to RMB8.6 million for the fourth quarter of 2023. * Adjusted net income[2] was RMB77.3 million (US$10.6 million)[1] compared to RMB60....

2025-04-24 19:38 3883

MINISO Group Announces Annual General Meeting on June 12, 2025, Filing of Annual Report on Form 20-F and Proposed Change of Auditors

GUANGZHOU, China, April 24, 2025 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today announced that it will hold an annual general meet...

2025-04-24 19:16 3797

NaaS Technology Inc. Announces Plan to Implement ADS Ratio Change

BEIJING, April 24, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced that that it will change the ratio of its American Depositary Shares (the "ADSs") to its Class A ordinary shares (the "...

2025-04-24 19:00 3766

Yunji Files 2024 Annual Report on Form 20-F

HANGZHOU, China, April 24, 2025 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that it has filed its annual report on Form 20-F for the fiscal year endedDecember 31, 2024 with the Securities and Exchange C...

2025-04-24 18:45 3353

Dizal to Showcase Data in Hematologic Malignancies and Lung Cancer at ASCO 2025

* DZD8586 study results in B-cell non-Hodgkin lymphomas (B-NHLs) were selected for oral and poster presentations. The analysis in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) after covalent or non-covalent BTK inhibitors and BTK degraders was selected for oral presentation ...

2025-04-24 18:38 2327
1 ... 979899100101102103 ... 779